Literature DB >> 14604289

Hyponatremia during administration of tacrolimus in an allogeneic bone marrow transplant recipient.

Taichi Azuma, Hiroshi Narumi, Kensuke Kojima, Yuichiro Nawa, Masamichi Hara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14604289     DOI： 10.1007/bf02983807

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

Review 1.  Adverse effects associated with the use of FK 506.

Authors:  J J Fung; M Alessiani; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; D Van Thiel; J Armitage; A Jain; J McCauley
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.

Authors:  A B Jain; J J Fung; S Todo; J Reyes; R Selby; W Irish; H Doyle; K Abu-Elmagd; A Casavilla; B Nour
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

3.  Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration.

Authors:  K Sakamoto; K Yamada; S Arita; K Hamaguchi; H Kashiwabara; T Yokoyama
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

Review 4.  Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.

Authors:  M Woo; D Przepiorka; C Ippoliti; D Warkentin; I Khouri; H Fritsche; M Körbling
Journal:  Bone Marrow Transplant       Date:  1997-12       Impact factor: 5.483

Review 5.  Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.

Authors:  T Y Chan
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923
  5 in total
  1 in total

1.  Tacrolimus-Induced Salt Losing Nephropathy Resolved After Conversion to Everolimus.

Authors:  Burak Sayin
Journal:  Transplant Direct       Date:  2015-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.